VivaGel phase 3 study results
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Later from Starpharma
- Targeted DEP shows sustained superior performance
- Starpharma licences VivaGel BV to Aspen for ANZ
- Adama Licenses Starpharmas Priostar for Novel 2,4-D
- DEP docetaxel - longer duration and increased exposure
- SPL: VivaGel condom approved for sale with launch imminent
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma